Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Conditions
- Unresectable Metastatic Colorectal Cancer
Interventions
- DRUG: CYAD-101
- DRUG: FOLFOX
- DRUG: Pembrolizumab
Sponsor
Celyad Oncology SA
Collaborators